Magscab (Skin) (100 ml) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Magnus Biotech Pvt. Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Cetrimide, Gamma Benzene Hexachloride. This drug comes in the form of Lotion. The general packing available for this medicine consists of 100 ml and is priced at Rs 36 (arround $0.504 US Dollar)
Generic (Salt) Combination :
(Cetrimide+ Gamma Benzene Hexachloride)
Pharma Company :
Magnus Biotech Pvt. Ltd.
Brand Label :
Magscab (Skin) (100 ml)
Preparation Type :
Lotion
Single Dose :
100 ml
Composition (Fixed-Dose Combination) :
Cetrimide-0.1% Gamma Benzene Hexachloride-1%
Pack Size/Qty/Vol :
100 ml
Price Unit :
Rs 36 INR (arround $0.504 US Dollar)
Price Pack :
Rs 36 INR (arround $0.504 US Dollar)
Drug details for Magscab (Skin) (100 ml)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Magscab (Skin) (100 ml) are :
Cetrimide-0.1% Gamma Benzene Hexachloride-1%
Cetrimide Indication (Prescribed for or used as): Skin disinfection.
For more details on Cetrimide, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Cetrimide..
Gamma Benzene Hexachloride Indication (Prescribed for or used as): Scabies, pediculosis.
For more details on Gamma Benzene Hexachloride, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Gamma Benzene Hexachloride..
Magscab (Skin) (100 ml) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 4 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Magscab (Skin) (100 ml), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Cetrimide-0.1% Gamma Benzene Hexachloride-1%). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.